Randomized, Placebo and Ciclosporin Controlled Study of ISA247 in Plaque Psoriasis Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andrzej Langner, Prof. Dr.
IWOLANG
Principal Investigator - Slawomir Majewski, Prof. Dr.
Akademia Medyczna
Principal Investigator - Thomas A. Luger, Prof. Dr.
Universität Münster
Principal Investigator - Wayne Gulliver, M.D.
NewLab Clinical Research
Principal Investigator - Wolfram Sterry, Prof. Dr.
Charite Universitatsmedizin Berlin
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
49 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Isotechnika Investigational Site
Edmonton, Alberta, Canada
- Isotechnika Investigational Site
Surrey, British Columbia, Canada
- Isotechnika Investigational Site
Vancouver, British Columbia, Canada
- Isotechnika Investigational Site
St. John's, Newfoundland and Labrador, Canada
- Isotechnika Investigational Site
St. John's, Newfoundland and Labrador, Canada
- Isotechnika Investigational Site
Halifax, Nova Scotia, Canada
- Isotechnika Investigational Site
Barrie, Ontario, Canada
- Isotechnika Investigational Site
London, Ontario, Canada
- Isotechnika Investigational Site
Markham, Ontario, Canada
- Isotechnika Investigational Site
North Bay, Ontario, Canada
- Isotechnika Investigational Site
Ottawa, Ontario, Canada
- Isotechnika Investigational Site
Waterloo, Ontario, Canada
- Isotechnika Investigational Site
Montreal, Quebec, Canada
- Isotechnika Investigational Site
Montreal, Quebec, Canada
- Isotechnika Investigational Site
Québec, Quebec, Canada
- Isotechnika Investigational Site
Ausburg, Germany
- Isotechnika Investigational Site
Berlin, Germany
- Isotechnika Investigational Site
Berlin, Germany
- Isotechnika Investigational Site
Berlin, Germany
- Isotechnika Investigational Site
Berlin, Germany
- Isotechnika Investigational Site
Bochum, Germany
- Isotechnika Investigational Site
Bochum, Germany
- Isotechnika Investigational Site
Dresden, Germany
- Isotechnika Investigational Site
Dresden, Germany
- Isotechnika Investigational Site
Frankfurt, Germany
- Isotechnika Investigational Site
Geiβen, Germany
- Isotechnika Investigational Site
Hamburg, Germany
- Isotechnika Investigational Site
Hamburg, Germany
- Isotechnika Investigational Site
Hansestadt Salzwedel, Germany
- Isotechnika Investigational Site
Kiel, Germany
- Isotechnika Investigational Site
Leipzig, Germany
- Isotechnika Investigational Site
Lübeck, Germany
- Isotechnika Investigational Site
Mahlow, Germany
- Isotechnika Investigational Site
Mainz, Germany
- Isotechnika Investigational Site
Münster, Germany
- Isotechnika Investigational Site
Potsdam, Germany
- Isotechnika Investigational Site
Wuppertal, Germany
- Isotechnika Investigational Site
Bialystock, Poland
- Isotechnika Investigational Site
Bydgoszcz, Poland
- Isotechnika Investigational Site
Gliwice, Poland
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2006
- Primary completion
- 31 Dec 2008
- Completion
- 31 Dec 2008
- Last update posted
- 30 Jul 2009
- Registered enrollment
- 642
- Registry id
- NCT00408187
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.